{"task_id": "e386c6d4c8ccd334", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 47/464)", "text": "2\nPericardial Diseases: Pericarditis and Tamponade\n\n--- Page 54 ---\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, troponin, CK\n\u0002\nIMAGING\nCXR (calcification if constrictive dis\nease), echocardiogram\n\u0002 ECG\nmay have sinus tachycardia, low voltages,\nand electrical alternans in tamponade/effusion;\ndiffuse ST elevation (concave up) and PR depres\nsion may be seen in pericarditis\nSPECIAL\n\u0002\nPERICARDIOCENTESIS\ndiagnostic or therapeutic\n(for tamponade, TB/bacterial pericarditis, or\nlarge persistent effusion)\n\u0002\nPERICARDIOSCOPY\n\u0002 CT/MRI CHEST\nif suspect constrictive pericarditis\nMANAGEMENT\nACUTE PERICARDITIS\nASA (650 mg PO TID \u00043 4\nweeks), NSAIDs (indomethacin 25 50 mg PO TID \u0004\n2 4 weeks). Add colchicine 0.6 mg PO BID \u00043\nmonths for adjuvant treatment and long term pro\nphylaxis. Prednisone 0.25 0.5 mg/kg PO daily may\nbe used for connective tissue mediated disease,\nalthough symptoms may recur upon withdrawal\nRECURRENT PERICARDITIS\nASA (650 mg PO TID\n\u00044 8 weeks) or NSAIDs (indomethacin 25 50 mg PO\nTID\u00044 8 weeks). Add colchicine (0.6 mg PO\nBID\u00042 months) for adjuvant treatment and long\nterm prophylaxis. Avoid anticoagulation as risk of\nhemopericardium. Prednisone 0.25 0.5 mg/kg PO\ndaily may also be useful, although symptoms may\nrecur upon withdrawal\nTAMPONADE\nABC, O2, IV\u2019s, bolus IV fluids, pericar\ndiocentesis (subxyphoid blind approach, echocardio\ngram guided parasternal or apical approach), pericar\ndiectomy, pericardial window if recurrent/malignant\neffusion. Avoid nitroglycerin and morphine if tampo\nnade as they may decrease preload, leading to worsen\ning of cardiac output\nCONSTRICTIVE PERICARDITIS\ncomplete pericar\ndiectomy\nSPECIFIC ENTITIES\nACUTE PERICARDITIS\nmay be preceded by upper\nrespiratory tract infection. Diagnosis is based on any\ntwo of the following inflammatory signs (LR+ 5.4):\nfever, pericardial friction rub (three components),\ncharacteristic chest pain (better with upright position\nand leaning forward, or pleuritic), PR depression, and\ndiffuse ST elevation. Large effusion without inflam\nmatory signs or tamponade suggests chronic idio\npathic pericardial effusion (LR+ 20)\nRECURRENT PERICARDITIS\nreturns in days to\nweeks upon stopping medications. Likely causes\ninclude rheumatologic disorders, Dressler\u2019s syn\ndrome, and post pericardiotomy syndrome\nTAMPONADE\na clinical diagnosis based on dyspnea,\ntachycardia, hypotension, pulsus paradoxus, and ele\nvated JVP. Tamponade causes restriction in left or right\nventricular diastolic filling. Tamponade with inflamma\ntory signs suggests malignant effusion (LR+ 2.9)\nCONSTRICTIVE PERICARDITIS\ncontraction of peri\ncardium due to chronic inflammation, leading to left\nand/or right heart failure. May follow pericarditis or\nradiation. May be difficult to distinguish from restric\ntive cardiomyopathy clinically\nHeart Failure\nNEJM 2003 348:20\nCanadian Heart Failure Guidelines 2006\nDIFFERENTIAL DIAGNOSIS OF HF EXACERBATION/\nDYSPNEA\nCARDIAC\n\u0002\nMYOCARDIAL\nHF\nexacerbation,\nmyocardial\ninfarction\n\u0002\nVALVULAR\naortic stenosis, acute aortic regurgita\ntion, mitral regurgitation/stenosis, endocarditis\n\u0002\nPERICARDIAL\ntamponade\n\u0002\nDYSRHYTHMIA\nRESPIRATORY\n\u0002\nAIRWAY\nCOPD exacerbation, asthma exacerba\ntion, acute bronchitis, bronchiectasis, foreign\nbody obstruction\n\u0002\nPARENCHYMA\npneumonia, cryptogenic organiz\ning pneumonia, ARDS, interstitial lung disease\nexacerbation\nDIFFERENTIAL DIAGNOSIS OF HF EXACERBATION/\nDYSPNEA (CONT\u2019D)\n\u0002\nVASCULAR\npulmonary\nembolism,\npulmonary\nhypertension\n\u0002\nPLEURAL\npneumothorax, pleural effusion\nSYSTEMIC\nsepsis, ARDS, metabolic acidosis, ane\nmia, neuromuscular, psychogenic, anxiety\nPATHOPHYSIOLOGY\nANATOMIC/PHYSIOLOGIC CLASSIFICATION OF\nCARDIOMYOPATHY\n\u0002\nDILATED (dilatation and impaired contraction of one\nor both ventricles)\nidiopathic, ischemic, valvular,\nviral, genetic, late manifestation of hypertrophic\nheart\ndisease,\ntachycardia\ninduced,\nalcohol\ninduced, peripartum\nMANAGEMENT (CONT\u2019D)\nHeart Failure\n33", "text_length": 3905, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 47/464)", "type": "chunk", "chunk_index": 46, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.295915", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.296593", "status": "complete", "chunks_added": 3}